Cambridge: Vesalius Therapeutics, a company pioneering a revolutionary platform to deliver breakthrough treatments for common ...

Deutsche Bank analyst Emmanuel Papadakis downgraded GSK (GSK) to Hold from Buy with a price target of 1,350 GBp, down from 1,700 GBp.

AstraZeneca and GSK fell as the president-elect named Kennedy as his pick for the role overseeing the US's rules on medicine, ...

GSK collaborates closely with Canadian sites — such as hospitals and other health-care centres — to operationalize its trials ...

U.K. stocks were lower after the close on Friday, as losses in the Pharmaceuticals & Biotech, Media and Food Producers ...

The UK stock market experienced declines with significant impacts from AstraZeneca and GSK, contributing to the FTSE 100's ...

The main UK stock indexes slipped on Friday, with losses in AstraZeneca and GSK weighing on the blue-chip FTSE 100, while data showed Britain's economy contracted unexpectedly in September.

Shares of several of the world’s largest vaccine makers fell Friday, the day after Donald Trump announced he had selected ...

Guggenheim's Inaugural Healthcare Innovation Conference November 12, 2024 2:00 PM ETCompany ParticipantsEmma Walmsley - Chief ...

The awards are presented annually to organizations in the Greater Philadelphia and Triangle (North Carolina) regions.

UK drugmaker GSK might be trading lower following Thursday’s nomination of vaccine sceptic Robert F Kennedy Jr as the USA’s ...

Deutsche Bank downgraded GSK (GSK) to Hold from Buy with a price target of 1,350 GBp, down from 1,700 GBp. The firm cites President-elect ...